In five retrospective patient samples selected from ALL-BFM 2000 for their high risk and known IKZF1-deletion profile, OGM was able to confirm all IKZF1 profiles (Table 1 and Table 2, Figure 1). This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.